US EditionUS Visa Seekers Could Face Rejection over Health Issues: Report
5 Articles
5 Articles
US visa seekers could face rejection over health issues: report
The visas of foreigners seeking residence in the US face the possibility of rejection if the applicants have certain medical conditions, including diabetes or obesity, according to US-based news outlet KFF Health News. The publication reported this on Thursday, citing a new directive from the Trump administration. According to the outlet, this new directive was outlined in a cable issued by the US State Department to embassy and consular officia…
The U.S. visa incorporates new guidelines that allow applicants with high risk or cost conditions to be denied the document. The U.S. government issued a directive that asks to review each person’s health and determine if it could become a “public burden.” This assessment focuses on chronic diseases and conditions that require long-term care. What diseases does the U.S. check when analyzing the U.S. visa? The memorandum expands the list of condi…
Former US President Donald Trump tightened immigration visa criteria, making it nearly impossible for people with diabetes, obesity, or heart disease to enter the country. Under the new mandate, these individuals will now be considered a "public burden."
According to a directive issued by the Trump administration on Thursday (November 6), visa officers will conduct more stringent health checks on all types of visa applicants, especially foreigners with certain serious illnesses such as diabetes or obesity, whose applications for U.S. residency visas may be rejected.
The Trump administration has issued new guidelines to embassies and consulates abroad that will prevent long-term U.S. visas for people with chronic medical conditions, such as diabetes and obesity. The move is aimed at preventing immigrants with noncommunicable diseases from overwhelming the U.S. healthcare system. On Thursday, President Donald Trump announced plans to make weight-loss drugs such as Ozempic and Wegovy more affordable for Americ…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
